Insider · CIK 0001734267
Ampersand 2018 Limited Partnership
Files at IDXG (INTERPACE BIOSCIENCES, INC.). First filing -, latest -.
In brief
Ampersand 2018 Limited Partnership files SEC Form 4 as 10% owner at IDXG (INTERPACE BIOSCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ampersand 2018 Limited Partnership has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | IDXG INTERPACE BIOSCIENCES, INC. | CConversion Common Stock | +13,861,386 | $2.02 | $28M | 13,861,386 | Feb 4, 2026 |
| Jan 20, 2026 | IDXG INTERPACE BIOSCIENCES, INC. | CConversion Series C Convertible Preferred Stockderivative | -28,000 | $0.00 | $0 | 0 | Feb 4, 2026 |
| Oct 11, 2024 | IDXG INTERPACE BIOSCIENCES, INC. | DDisposition to issuer Series B Convertible Preferred Stockderivativeindirect: See Footnotes | +28,000 | - | - | 0 | Oct 15, 2024 |
| Oct 11, 2024 | IDXG INTERPACE BIOSCIENCES, INC. | AGrant or award Series C Convertible Preferred Stockderivativeindirect: See Footnotes | +28,000 | - | - | 28,000 | Oct 15, 2024 |
Questions about Ampersand 2018 Limited Partnership
Answered from the filings on this page, as of the latest one.
Is Ampersand 2018 Limited Partnership buying or selling?
Ampersand 2018 Limited Partnership has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ampersand 2018 Limited Partnership's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ampersand 2018 Limited Partnership has 0.
Where does Ampersand 2018 Limited Partnership file Form 4?
Ampersand 2018 Limited Partnership has filed Form 4 at IDXG (INTERPACE BIOSCIENCES, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.